! I’m your host today, Jessica Hergert.

, which provides oncology professionals with the resources and information they need to provide the best patient care. In both digital and print formats, 

 covers every angle of oncology practice, from new technology to treatment advances to important regulatory decisions.

In today’s episode, we had the pleasure of speaking with Shubham Pant, MD, an associate professor in the departments of Investigational Cancer Therapeutics and Gastrointestinal Medical Oncology, and associate director in the Department of Sheihk Ahmed Center for Early Phase Drug Development of Pancreatic Cancer Research, in the Division of Cancer Medicine, at The University of Texas MD Anderson Cancer Center, to discuss the landscape of targeted therapy in pancreatic cancer.

In our exclusive interview, Pant discussed the current role for germline and somatic testing in pancreatic cancer, examined the research landscape with PARP inhibitors, KRAS inhibitors, and other targeted agents, and shared his hope for the future of drug development in the field.

Podcasts

that provides oncology professionals with the resources and information they need to provide the best patient care. Segments cover every angle of oncology practice, from new technology to treatment advances to important regulatory decisions. New episodes with exclusive interviews with leading oncology experts are released on Mondays and Thursdays. 

Gastrointestinal Cancer

The OncLive Gastrointestinal Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of gastrointestinal (GI) cancers, including hepatocellular carcinoma, gastric cancer, pancreatic cancer, colorectal cancer, cholangiocarcinoma, esophageal cancer, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in GI cancers.

Precision Medicine in Oncology®

The OncLive Precision Medicine in Oncology® condition center page is a comprehensive resource for clinical news and expert insights on precision-focused approaches in patients with cancer, with gene-targeted tyrosine kinase inhibitors and antibody-drug conjugates, checkpoint inhibitors, tumor-infiltrating lymphocyte therapy, and other tailored treatments. This page features news articles, interviews in written and video format, and podcasts that focus on updates and ongoing research with personalized therapies across solid and hematologic tumors.

Oncology Expert Insights

The University of Texas MD Anderson Cancer Center

Cancer Centers

Partner

Dr. Pant discusses the current role for germline and somatic testing in pancreatic cancer, examines the research landscape with PARP inhibitors, KRAS inhibitors, and other targeted agents, and shares his hope for the future of drug development in the field.

Pant Projects an Expanding Role for Targeted Therapy in Pancreatic Cancer